Effect of tumor necrosis factor alpha on biodistribution of an anti-epidermal growth factor receptor (EGFr) monoclonal antibody in vivo

Medicine and Dentistry

• Tumor Necrosis Factor 100%
• Monoclonal Antibody 100%
• Biodistribution 100%
• Anti-Epidermal Growth Factor Receptor 100%
• Epidermal Growth Factor Receptor 66%
• Tumor 50%
• Neoplasm 33%
• In Vitro 16%
• Receptor 16%
• Nitric Oxide 16%
• Arginine 16%
• Iodine 125 16%
• Iodine 131 16%
• Vascular Endothelial Cell 16%
• Receptor Expression 16%
• Tumor Xenograft 16%
• Melanoma Cell 16%
• Upregulation 16%
• Table Salt 16%
• Cell Damage 16%
• Liver Tumor 16%
• Melanoma Cell Line 16%
• Intravenous Injection 16%

Keyphrases

• Tumor Necrosis Factor-α 100%
• Biodistribution 100%
• Anti-epidermal Growth Factor Receptor Monoclonal Antibodies 100%
• Tumor 50%
• Epidermal Growth Factor Receptor 50%
• Monoclonal Antibody 33%
• Melanoma Cells 33%
• Fold Increase 16%
• Intravenous Injection 16%
• Nitric Oxide Production 16%
• Iodine-131 (131I) 16%
• Injected Dose 16%
• Nude Mice 16%
• Arginine 16%
• Tumor Targeting 16%
• Selective Inhibitor 16%
• 125I 16%
• Methyl 16%
• Epidermal Growth Factor Receptor Expression 16%
• Human Tumor Xenograft 16%
• Tumor Location 16%
• Saline Control 16%
• Normal Saline 16%
• Liver Tumor 16%
• Vascular Endothelial Dysfunction 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Epidermal Growth Factor Receptor 100%
• Tumor Necrosis Factor 100%
• Monoclonal Antibody 100%
• Biodistribution 100%
• Neoplasm 50%
• Melanoma 33%
• Nude Mouse 16%
• Receptor 16%
• Iodine-131 16%
• Iodine-125 16%
• Nitric Oxide 16%
• Arginine 16%
• Table Salt 16%
• Liver Tumor 16%